Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Arnold

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Bioanalysis|February 27, 2014
Sensitivity-based analytical approaches to support human absolute bioavailability studiesXiaohui Sophia Xu, Hao Jiang, Lisa J Christopher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2014
Bioanalysis of propylparaben and p-hydroxybenzoic acid, and their sulfate conjugates in rat plasma by liquid chromatography-tandem mass spectrometryYue Zhao, Guowen Liu, Hongwu Shen, et al.
Bioanalysis|December 22, 2012
Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studiesXiaohui Xu, Qin C Ji, Mohammed Jemal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 25, 2014
Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assayLong Yuan, Yunlin Fu, Duxi Zhang, et al.
Bioanalysis|September 10, 2016
A validated LC-MS/MS method for the quantitative measurement of creatinine as an endogenous biomarker in human plasmaYue Zhao, Guowen Liu, Aida Angeles, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 2, 2015
A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasmaJane Liu, Long Yuan, Guowen Liu, et al.
Analytical Chemistry|June 23, 2011
A convenient strategy for quantitative determination of drug concentrations in tissue homogenates using a liquid chromatography/tandem mass spectrometry assay for plasma samplesHao Jiang, Jianing Zeng, Naiyu Zheng, et al.
Journal of Chromatography. A|May 30, 2012
A sensitive and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urineHao Jiang, Jianing Zeng, Hamza Kandoussi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2015
Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MSAng Liu, John Lute, Huidong Gu, et al.
Biomedical Chromatography : BMC|March 29, 2002
High performance liquid chromatographic-mass spectrometric assay for the quantitation of BMS-204352 in dog K(3)EDTA plasmaMing Yao, Subbarao Mantha, Vinod R Shah, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Bioanalysis|February 27, 2014
Sensitivity-based analytical approaches to support human absolute bioavailability studiesXiaohui Sophia Xu, Hao Jiang, Lisa J Christopher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2014
Bioanalysis of propylparaben and p-hydroxybenzoic acid, and their sulfate conjugates in rat plasma by liquid chromatography-tandem mass spectrometryYue Zhao, Guowen Liu, Hongwu Shen, et al.
Bioanalysis|December 22, 2012
Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studiesXiaohui Xu, Qin C Ji, Mohammed Jemal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 25, 2014
Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assayLong Yuan, Yunlin Fu, Duxi Zhang, et al.
Bioanalysis|September 10, 2016
A validated LC-MS/MS method for the quantitative measurement of creatinine as an endogenous biomarker in human plasmaYue Zhao, Guowen Liu, Aida Angeles, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 2, 2015
A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasmaJane Liu, Long Yuan, Guowen Liu, et al.
Analytical Chemistry|June 23, 2011
A convenient strategy for quantitative determination of drug concentrations in tissue homogenates using a liquid chromatography/tandem mass spectrometry assay for plasma samplesHao Jiang, Jianing Zeng, Naiyu Zheng, et al.
Journal of Chromatography. A|May 30, 2012
A sensitive and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urineHao Jiang, Jianing Zeng, Hamza Kandoussi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2015
Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MSAng Liu, John Lute, Huidong Gu, et al.
Biomedical Chromatography : BMC|March 29, 2002
High performance liquid chromatographic-mass spectrometric assay for the quantitation of BMS-204352 in dog K(3)EDTA plasmaMing Yao, Subbarao Mantha, Vinod R Shah, et al.
Pageof 9